ARX stock · PODD stock

ARX vs PODD · rev $912.9M vs P/E 34, rev $2.07B

Accelerant Holdings (ARX) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.

Accelerant Holdings (ARX) is a insurance brokers company listed on NYSE.

Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.

Latest reported ARX revenue for 2025-12-31 was $912.9M. Net income was -$1.35B. Revenue was up 51.5% from 2024-12-31 to 2025-12-31. ARX currently screens at market cap $2.84B.

Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.

ARX currently screens at market cap $2.84B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.

Not investment advice. Open the ARX and PODD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons